SCHEMBL8767955

SCHEMBL8767955

C[C@]1(O)C=C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3[C@@H](c3ccccc3-c3ccoc3)C[C@@]21C

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PGR P06401 11/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ HIF1A Q16665 2/20 0.37
▸ MCL1 Q07820 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ NR3C1 P04150 7/20 0.36
▸ AR P10275 9/20 0.36
▸ NR3C2 P08235 2/20 0.35
▸ LMNA P02545 3/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ SLC6A4 P31645 1/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ CYP3A4 P08684 3/20 0.34
▸ TSHR P16473 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ ABCB11 O95342 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8768257 0.85 PGR (0.46) PGRALDH1A1HIF1ANR3C1AR
SCHEMBL8767749 0.76 NR3C1 (0.49) PGRALDH1A1HIF1ANR3C1AR
SCHEMBL8769036 0.75 NR3C1 (0.44) PGRALDH1A1HIF1ANR3C1AR
SCHEMBL8768876 0.74 PGR (0.61) PGRHIF1ACYP1A2NR3C1AR
SCHEMBL8767722 0.74 PGR (0.48) PGRALDH1A1HIF1ANR3C1AR
SCHEMBL8767961 0.74 PGR (0.48) PGRALDH1A1HIF1ANR3C1AR
SCHEMBL8768013 0.74 PGR (0.41) PGRALDH1A1HIF1ANR3C1AR
SCHEMBL8768881 0.74 PGR (0.41) PGRALDH1A1HIF1ANR3C1AR
SCHEMBL8767959 0.73 NR3C1 (0.46) PGRALDH1A1HIF1ANR3C1AR
SCHEMBL8768908 0.73 NR3C1 (0.46) PGRALDH1A1HIF1ANR3C1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567469-B1 14beta-H-, 14- AND 15-EN-11beta-ARYL-4-ESTRENES SCHERING AG (DE) 1997-08-27 — — EP disclosed
US-5426102-A Antigestagenic, antiandrogenic, antiglucocorticoid, antimineralcorticoid properties SCHERING AKTIENGESELLSCHAFT (DE) 1995-06-20 — — US disclosed
Send feedback